News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Related Stories Digital Transformation News CORRECTING and REPLACING Vouched Developing Integration in Epic Toolbox Under Construction for Remote Identity Verification News Wells Fargo Scandal Drove Borrowers to Fintech Lenders, UC Davis Study Suggests News CertiK Cements Institutional Presence After CEO’s Strategic Engagements in Hong Kong News UOB Hong Kong becomes first Singapore-based bank to sign MOU with HKTDC News INVEST FAIR Malaysia 2025 Spotlights Investor Trends, Multi-Asset Literacy, and Tech-Driven Platforms News Clara Technologies Announces Sales Buddi Launch on Google Play Store, Extending Global Reach of Quantum-AI Sales Platform
